Clinical Immunology · 2015 · 36 citations · 18 references
Life SciencesGeneticsImmunologyHuman GeneticsHypersensitivityMedical GeneticsEnzyme DeficienciesGenetic DisordersImmunodeficiency DisordersImmunoglobulin DisordersPrimary ImmunodeficiencyPrimary Immunodeficiency GeneticsCongenital Disorders Of GlycosylationCongenital Glycosylation DisordersGlycosylation DefectsHyper-ige SyndromeMissense MutationsMutationPhosphoglucomutase DeficiencyPrimary Immunodeficiency Disorders
Phosphoglucomutase 3 (PGM3) is an enzyme converting N-acetyl-glucosamine-6-phosphate to N-acetyl-glucosamine-1-phosphate, a precursor important for glycosylation. Mutations in the PGM3 gene have recently been identified as the cause of novel primary immunodeficiency with a hyper-IgE like syndrome. Here we report the occurrence of a homozygous mutation in the PGM3 gene in a family with immunodeficient children, described already in 1976. DNA from two of the immunodeficient siblings was sequenced and shown to encode the same homozygous missense mutation, causing a destabilized protein with reduced enzymatic capacity. Affected individuals were highly prone to infections, but lack the developmental defects in the nervous and skeletal systems, reported in other families. Moreover, normal IgE levels were found. Thus, belonging to the expanding group of congenital glycosylation defects, PGM3 deficiency is characterized by immunodeficiency, with or without increased IgE levels, and with variable forms of developmental defects affecting other organ systems.
18
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling
Konstantin Arnold, Lorenza Bordoli, Jürgen Kopp et al. · Bioinformatics · 2005 · 7.1K citations · Full text
Raheel Shafi, Sai Prasad N. Iyer, Lesley G. Ellies et al. · Proceedings of the National Academy of Sciences · 2000 · 795 citations
Yu Zhang, Xiaomin Yu, Mie Ichikawa et al. · Journal of Allergy and Clinical Immunology · 2014 · 244 citations · Full text